secwatch.observer — SEC 8-K summary
======================================

Issuer:     IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK:        0001425205
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001104659-26-032774
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Wendy Yarno to retire from Iovance board at 2026 annual meeting
------------------------------------------------------------------------

- Wendy Yarno will retire and not stand for re-election at the June 2026 annual meeting.
- Yarno will serve out her current director term until the annual meeting.
- Retirement is not due to any disagreement with the company on operations, policies, or practices.
- No replacement director has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425205/000110465926032774/0001104659-26-032774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425205/000110465926032774/tm269367d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-032774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer